Last10K.com

Adagene Inc. (ADAG) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, March 31, 2021

Adagene Inc.

HISTORY TOOLS
CIK: 1818838 Ticker: ADAG

View differences made from one to another to evaluate Adagene Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Adagene Inc..

Continue

Assess how Adagene Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Adagene Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Adagene Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: ADAG
CIK: 1818838
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-21-036674
Submitted to the SEC: Tue Mar 16 2021 8:10:37 AM EST
Accepted by the SEC: Tue Mar 16 2021
Period: Wednesday, March 31, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/adag/0001104659-21-036674.htm